#United States #Exton #West Pharmaceutical #Prefillable Syringe #Synchrony S1

West Synchrony™ S1 Prefillable Syringe System Launched at Pharmapack 2026

West Pharmaceutical Services, Inc. (NYSE: WST), a leading player in the field of injectable drug administration solutions, has announced the availability of its latest innovation, the West Synchrony™ S1 prefillable syringe system, at Pharmapack 2026 held in Paris, France. This event underscores West’s ongoing commitment to addressing the challenges and trends within the packaging and containment space of the pharmaceutical industry.

A Significant Milestone

The introduction of the Synchrony S1 marks a significant milestone for West Pharmaceutical Services. This prefillable syringe system is designed to provide a fully integrated and verified solution, enhancing the interaction between various components for reliable and efficient drug delivery performance.

The company’s prefillable syringe system offers a diverse product portfolio with options suited for various medical applications. Specifically, these include 1 ml long and 2.25 ml staked needle configurations aimed at biologics, along with standard staked needle and Luer lock variants for vaccines. The flexibility provided by including both rigid and soft needle shields makes this product adaptable to various medical needs.

Industry Leading Insights

According to Stacey Vaughan, Vice President of Marketing and Portfolio Management at West, the current healthcare landscape is experiencing a marked shift, particularly the growing demand for combination products and the transition of care from hospitals to home settings. Vaughan states, “This surge of innovation across the industry further highlights why now is the right time to introduce the Synchrony S1 prefillable syringe system.” This statement reflects West's position as a leader closely observing the global drug pipeline, especially from emerging companies. The transition highlights the complexities that come with new regulatory and development processes, a point of focus for attendees at Pharmapack.

In addition to the launch, West will be leveraging the event to establish its industry expertise through a series of engaging learning labs and product demonstrations scheduled for January 21 and 22. These sessions will address critical themes, including the importance of integrated systems and flexible assembly approaches to navigate the evolving landscape of combination products in clinical trials.

Learning Labs at Pharmapack

Participants at the Pharmapack event will have the opportunity to join several discussions led by industry experts:

• - Stop Piecing It Together: An in-depth look at integrating prefillable syringe systems from a single source, led by Bettine Boltres, Ph.D., Director of Scientific Affairs.
• - Product Gallery - West Synchrony S1 PFS System: A showcase of the product functionalities, presented by Andy Polywacz, President of Integrated Systems.
• - Flexible Assembly and Packaging Approach: Discussing strategies to effectively steer combination products through clinical trials, led by Richard Kieran, Director of Business Development.

Conclusion

With over 10,000 team members across 50 sites globally and an annual revenue of $2.89 billion, West Pharmaceutical Services continues to position itself at the forefront of drug delivery capabilities. It remains steadfast in its mission to support pharmaceutical developers in delivering safe and effective medications that positively impact patient health. As the company moves forward with the West Synchrony S1 prefillable syringe system, it promises a new era of innovation that aligns with the industry's future needs. For more information about the product and its features, interested parties can visit West Pharmaceutical’s official website.